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Abstract 
Background: Ocular allergies frequently present in pharmacy practices. However, research 
into the actual management of ocular allergy in pharmacies is lacking.  
Objective: To determine and quantify history and symptom questioning of a patient with 
presumed allergic conjunctivitis and management strategies employed by pharmacy staff in 
the UK  
Method: A mystery shopper technique was used to simulate an episode of allergic 
conjunctivitis in 100 community pharmacies across the UK.  
Results: The mean number of questions asked by pharmacy staff to the patient was 
3.5±2.6, with a range of 0-10. The most common question was whether the patient had a 
history of allergies (45%).Ninety-one percent advised on treatment, with the remaining 9% 
directly referring to the patient’s general practitioner (n=4) or pharmacist(n=4), but only two  
to their optometrist. The most common treatment suggested was sodium cromoglycate 2% 
(50%). However, many pharmacies advising treatment did not ask the patient’s age (37%), if 
they wore contact lenses (43%), or gave dosage advice (43%). Only 5% of pharmacies 
advised follow up and 14% suggested visiting a general practitioner and 1% an optometrist if 
symptoms did not resolve with treatment.   
Conclusion: There is a need for improved ophthalmological training for pharmacy staff with 
respect to the management of allergic conjunctivitis  
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Impact of Findings on Practice 
 Pharmacy staff should not attempt to differentially diagnose or manage allergic 
conjunctivitis without formal training or knowledge of the condition and eye disease.  
 If the diagnosis of allergic conjunctivitis is in doubt, the patient must be referred to a 
member of staff with formal training or knowledge of the condition and eye disease or to 
the patient’s optometrist.  
 Careful consideration of the contraindications of ophthalmic preparations for allergic 
conjunctivitis is required if they are advised.  
  
Introduction 
Ocular allergy affects approximately 20% of the allergy suffering population, representing a 
group of disorders that primarily affects the conjunctiva1.Ocular allergies are often under-
diagnosed and under-treated, with ocular signs and symptoms considered part of other 
allergies rather than a distinct clinical entity2. Ocular allergies adversely impact on quality of 
life, school performance and work productivity and therefore pose a significant problem that 
needs to be managed appropriately2.     
It has been estimated that 3% of patients consulting a pharmacist suffer from ocular allergy3. 
Combined with the availability of many anti-allergic preparations over the counter, 
pharmacists and pharmacy staff (under supervision of pharmacist) are required to 
differentially diagnose and manage ocular allergies based upon history and symptoms alone 
as they do not have access or training in using ophthalmic examination instruments. 
Furthermore, the signs and symptoms of ocular allergic disease may not be present at the 
time of a consultation1. However, research into the actual diagnosis and management of 
ocular allergy by pharmacists and pharmacy staff, has not been widely studied3.  
Objective  
This study aimed to determine and quantify the history and symptom questioning of a patient 
with presumed allergic conjunctivitis and management strategies employed by pharmacists 
and pharmacy staff in the UK. 
  
Method  
A mystery shopper technique was used in 100 community pharmacies, selected using a 
randomised sampling technique, across the UK by 4 trained investigators, each visiting 
different practices alone. Pharmacies were a mixture of independent (n=38) and chain 
(n=62) practices. At each pharmacy the investigator approached the counter and when 
acknowledged by a staff member made the following opening statement: 
“My brother’s eyes are red and itchy. What would you recommend?” 
The investigators answered the above questions only when asked but did not volunteer any 
information other than the opening statement. Immediately after leaving each pharmacy 
practice the consultation details were recorded in a table. It was expected that the mystery 
shopper should have been asked about their brother’s age, current medications, whether 
they were a contact lens wearer, ocular history, history of allergies, past treatments / 
examinations and symptoms in more detail such as severity, duration, unilateral or bilateral, 
seasonality, pain and any discharge.4 Data was analysed using Microsoft Excel (Microsoft, 
USA). The study received Aston University ethics committee approval and the research 
conformed to the tenets of the Declaration of Helsinki. 
  
Results      
Out of a total of 100 pharmacy practices, 11% of consultations took place with a pharmacist, 
21% with a pharmacy assistant or trainee dispenser, 8% with staff with ambiguous job titles, 
but in 60% of consultations it was not possible to determine the professional status as 
identification badges or labels were not visible or not worn.  
The mean number of history and symptom questions asked by pharmacy staff was 3.5±2.6, 
ranging from 0-10.  Eleven percent of pharmacy staff asked additional questions - if there 
was blood in or on the eye; the patient had a cold; used cosmetics; the eyes felt gritty; any 
eyelid swelling; whether a personal computer was used frequently; and if a new laundry 
powder had been used. The questions asked by the pharmacy staff is presented in figure 1.    
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The majority of practices advised treatment (91%, n=91), with most of these recommending 
pharmacological treatments (96%, n=87) mainly in the form of topical eye drops (97%, 
n=84). Four percent (n=4) of the treatments were non-pharmacological, and included 
allergen avoidance and use of hypromellose. Those pharmacies that did not recommend 
treatment (9.0%, n=9) referred the patient to their general practitioner (n=4) or pharmacist 
(n=4) but only two referred to an optometrist. The treatments advised by the pharmacies are 
shown in figure 2. 
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Discussion 
A mystery shopper technique was used to simulate a realistic consultation to determine the 
history and symptoms questioning of a patient with presumed allergic conjunctivitis and 
management recommended by community pharmacies across the UK. Pharmacies were not 
informed that the study was being conducted, thus eliminating the possibility of the 
Hawthorne effect influencing the outcome of the consultation. Although some authors have 
suggested mystery shopping techniques are unethical, such criticisms relate to competitive 
intelligence gathering between competing businesses5. Patient satisfaction is insufficient to 
fully evaluate healthcare service provision and safety alone, as patients often lack the 
expertise to formulate criteria to measure performance6. In addition, some authors argue that 
it is impossible to fully evaluate healthcare without using deceptive methods7.  Analysis of 
patient records may be used to evaluate diagnostic and management performance, but 
pharmacies do not generally offer private consultations, or keep patient records. Mystery 
shopping techniques have previously been employed extensively in healthcare research to 
evaluate provision of specific services, but none have investigated the management of eye 
disease, such as ocular allergy, in community pharmacies. 
The low number of questions asked on average in the present study are consistent with the 
low number of criteria covered on average by pharmacists when diagnosing ocular allergy in 
the study by Wolffsohn (2009)3. The high proportion of pharmacies suggesting treatments 
compared to referral implies that pharmacy staff are confident in their abilities to diagnose 
and treat allergic conjunctivitis. This is supported by very few pharmacies advising referral to 
another healthcare professional to confirm diagnosis or for further investigation (14%, n=13) 
and is consistent with a previous study3 where all pharmacists recommended treatment. 
Perhaps pharmacy staff perceive ocular symptoms as part of a systemic allergy rather than 
as a uniquely sensitised tissue. Despite their advanced instrumentation to examine the eyes 
to allow differential diagnosis when symptomology is not conclusive, only 2 pharmacies in 
this study recommended referral to an optometrist. This may be due to a lack of awareness 
by the public and other healthcare professionals of the abilities and role of optometrists in 
primary eye care. Conversely, optometrists may not be promoting or communicating their 
abilities effectively.  
Preventing or minimising exposure to the causative allergen prevents the development of a 
hypersensitivity response1,8. However, allergen avoidance advice was given in less than 2% 
of pharmacies which concurs with a previous study with UK pharmacists3. Half the 
pharmacies advised the use of sodium cromoglycate 2%, whose efficacy compared to 
placebo in the treatment of allergic conjunctivitis has been demonstrated in both 
environmental studies and conjunctival challenge models1,8. However, their mechanism of 
action result in a significant delay of up to several weeks in treating ocular allergy and an 
antihistamine would be more appropriate for initial symptomology management1. 
Interestingly, none of the pharmacies recommended lodoxamide trometamine 0.1%, a mast 
cell stabiliser which produces a greater and faster clinical improvement in ocular allergy than 
sodium cromoglycate 2%9. The second most common treatment was topical witch hazel 
(hamamelis virginiana), a plant extract with purported astringent properties. However, there 
is no evidence in the scientific literature regarding its pharmacological action or its efficacy in 
treating ocular allergies. 
 The vasoconstrictor naphazoline hydrochloride has been shown to be more effective in 
treating allergic conjunctivitis than a placebo10. However, there appears to be no scientific 
literature on xylometazoline-antazoline in treating allergic conjunctivitis, although one study 
found mild vasoconstriction of conjunctival blood vessels in the eyes of 16 healthy 
volunteers11. Of concern is that only one of the pharmacies recommending these products 
asked the patient’s age or whether they had concurrent medical conditions or eye disease. 
Topical sympathomimetics are contraindicated in patients with glaucoma and should be 
used with caution in patients with heart disease, high blood pressure and diabetes8.  
Oral antihistamines are indicated where systemic allergies are present such as hay fever in 
addition to ocular signs and symptoms; although they are not as effective as topical anti-
allergic medications in treating allergic conjunctivitis, efficacy improves when they are 
combined8. Hypromellose, an artificial tear supplement, may aid removal of allergens from 
the ocular surface and act as barrier to further allergen exposure8. Cooled artificial tears and 
cold compresses may also cause vasoconstriction of the conjunctival blood vessels and 
bring about symptomatic relief8. However, despite several authors recommending their use, 
scientific evidence is lacking. Incorrect treatment advice was low (6%, n=6) where the 
antibacterial brolene (propamidine isetionate 0.1%) was recommended. However, only a 
third of these pharmacies asked if the patient had stickiness or crusting of the eyelids/lashes 
and if they had any discharge from the eye, key questions in the differential diagnosis 
between bacterial and allergic conjunctivitis1,2,4.  
Less than half of pharmacies recommending treatment asked about contact lens wear (41%, 
n=37). Topical administration of medications requires removal of contact lenses as the active 
ingredients and preservatives can bind to the contact lens and prolong exposure which may 
result in ocular toxicity or drug-induced allergic inflammation2    
Hence there is a need for improved ophthalmology training and support for ocular allergy 
management in community pharmacy, as treatments can be purchased without prescription. 
If the diagnosis is in doubt, pharmacists should refer patients with suspected ocular allergy 
to healthcare professionals with equipment available to examine the eyes, such as 
optometrists. If pharmacological treatments are advised, only those which demonstrate 
efficacy should be recommended on an individual patient basis.  
  
Conclusions.    
The differential diagnosis questioning and management of allergic conjunctivitis by 
community pharmacies in the UK is currently lacking and more training is warranted.  
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